Abstract
Rapid estrogen actions are triggered after estrogens are bound to a variety of proteins in organelles other than the nucleus. Those include classic estrogen receptors ERα and ERβ, novel membrane proteins that behave as estrogen receptors such as GPR30, ion channels, and other ligand receptors. In pancreatic α and β-cells, estrogens binding to a non-classical membrane estrogen receptors at physiological concentrations regulate ion channels and [Ca2+]i signals, provoking important physiological responses. In β-cells, 17β- estradiol regulates KATP channel activity and glucose-induced [Ca2+]i oscillations, eliciting changes in insulin release and the activation of Ca2+-dependent transcription factors. In α-cells, 17β-estradiol abolishes low glucose-induced [Ca2+]i oscillations.
Infectious Disorders - Drug Targets
Title: Rapid Regulation of Pancreatic α- and β- Cell Signalling Systems by Estrogens
Volume: 8 Issue: 1
Author(s): Cristina Ripoll, Ana B. Ropero, Paloma Alonso-Magdalena, Ivan Quesada, Esther Fuentes and Angel Nadal
Affiliation:
Abstract: Rapid estrogen actions are triggered after estrogens are bound to a variety of proteins in organelles other than the nucleus. Those include classic estrogen receptors ERα and ERβ, novel membrane proteins that behave as estrogen receptors such as GPR30, ion channels, and other ligand receptors. In pancreatic α and β-cells, estrogens binding to a non-classical membrane estrogen receptors at physiological concentrations regulate ion channels and [Ca2+]i signals, provoking important physiological responses. In β-cells, 17β- estradiol regulates KATP channel activity and glucose-induced [Ca2+]i oscillations, eliciting changes in insulin release and the activation of Ca2+-dependent transcription factors. In α-cells, 17β-estradiol abolishes low glucose-induced [Ca2+]i oscillations.
Export Options
About this article
Cite this article as:
Ripoll Cristina, Ropero B. Ana, Alonso-Magdalena Paloma, Quesada Ivan, Fuentes Esther and Nadal Angel, Rapid Regulation of Pancreatic α- and β- Cell Signalling Systems by Estrogens, Infectious Disorders - Drug Targets 2008; 8 (1) . https://dx.doi.org/10.2174/187152608784139668
DOI https://dx.doi.org/10.2174/187152608784139668 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Retromer Dysfunction and Neurodegenerative Disease
Current Genomics Genome-Wide Association Studies: Is there a Genotype for Cognitive Decline in Older Persons with Type 2 Diabetes?
Current Pharmaceutical Design Chemical and Pharmacological Significance of Natural Guanidines from Marine Invertebrates
Mini-Reviews in Medicinal Chemistry Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease
Letters in Drug Design & Discovery Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Current Cancer Drug Targets Measurement of the Cellular Hemoglobin Concentration by Laser Scatter Method from Excessive Lipemic Sample: CASE REPORT
Combinatorial Chemistry & High Throughput Screening New-Onset Hyperglycemia and Acute Coronary Syndrome: A Systematic Overview and Meta-Analysis
Current Diabetes Reviews CD31+ Circulating Angiogenic Cell Number and Subtypes are Reduced in Individuals with Chronic Stroke
Current Neurovascular Research Recent Advances in the Treatment of Amyotrophic Lateral Sclerosis. Emphasis on Kynurenine Pathway Inhibitors
Central Nervous System Agents in Medicinal Chemistry Effect of Electromagnetic Field on the Polymerization of Microtubules Extracted from Rat Brain
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Endurance Exercise Training and Reproductive Endocrine Dysfunction in Men Alterations in the Hypothalamic-Pituitary-Testicular Axis
Current Pharmaceutical Design Innate Immunity in the Female Reproductive Tract: Role of Sex Hormones in Regulating Uterine Epithelial Cell Protection Against Pathogens
Current Women`s Health Reviews The Role of Nutrition During the COVID-19 Pandemic: What We Know
Endocrine, Metabolic & Immune Disorders - Drug Targets Diabetes Mellitus: Novel Insights, Analysis and Interpretation of Pathophysiology and Complications Management with Imidazole-Containing Peptidomimetic Antioxidants
Recent Patents on Drug Delivery & Formulation Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Epidemiology and Health Effects of Tobacco Use
Current Pediatric Reviews IN MEMORIAM
Endocrine, Metabolic & Immune Disorders - Drug Targets Telmisartan in the Management of Diabetic Nephropathy: A Contemporary View
Current Diabetes Reviews The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Atherosclerosis
Current Stem Cell Research & Therapy Protective Role of Gallic Acid Isolated from Peltiphyllum Peltatum Against Sodium Fluoride-Induced Oxidative Stress in Rat’s Heart
Letters in Drug Design & Discovery